Comparison
eBloodConnect vs Sara Technologies: comparing blood bank software for an Indian blood centre
A general software services company with a blood bank product, against a product company that specialises in this domain. Both models work; they fail differently.
We wrote this page, so here is what it will and will not do
eBloodConnect built this page. Do not accept our account of a competitor's product as verified fact — we are not offering a tick-and-cross matrix. We cannot see inside Sara Technologies at a live centre.
What follows instead: how Sara Technologies describes itself from public material; the reason a reader might reasonably choose them; what eBloodConnect does, stated specifically enough to hold us to; and three questions to put to both of us. If any of those questions gets a worse answer from us than from them, choose them.
If you work at Sara Technologies and something here is out of date or wrong, write to us and we will correct it.
Sara Technologies
How Sara Technologies positions itself
Summarised from the vendor's own public material.
Sara Technologies is an IT services company operating in India and the United States, offering a blood bank management system among a broad portfolio of software development and IT services rather than as its sole product.
Why you might choose Sara Technologies over eBloodConnect
A services company will build what you ask for. If your requirement is genuinely unusual — a state format nobody else needs, an integration with a local system, or a trust-specific workflow — a firm that does custom development may implement it where a product vendor puts it on a roadmap or declines.
Likely to suit: A centre with an unusual requirement and the budget and patience for bespoke development.
Key differentiator
Shared product releases + ABDM M1–M3 for every centre
eBloodConnect is a product BBMS: centres share a release cycle, including ABDM M1–M3 and eRaktKosh updates absorbed across the customer base rather than quoted per client when national schemas move. Custom one-offs can solve unique needs — and can also leave you alone when regulations shift.
eBloodConnect
What eBloodConnect does, stated so you can hold us to it
Every line below is testable in a demo. Ask us to fail one.
ABDM M1, M2 & M3 — direct API, not a bolt-on
eBloodConnect is ABDM-certified across milestones M1 (ABHA creation & verification), M2 (health facility / record sharing), and M3 (consent-based health information exchange). ABHA lookup and ABDM workflows run on our direct integration — not a third-party ABDM wrapper. Ask us to create or verify an ABHA ID and walk M2/M3 flows in the demo.
Gates enforced at issue, not advisory
A component cannot be allotted until grouping and TTI screening are complete and the unit is in tested stock. A reactive result moves the bag out of issuable stock automatically. Emergency release before crossmatch is possible when clinically required, and it is flagged on the request rather than passing silently.
Registers generated, not retyped
Statutory registers and returns — including donor, grouping, TTI, component preparation, stock, crossmatch, issue, patient-recipient, and discard — are generated from the work your staff already entered, with formats your state council expects.
eRaktKosh submitted from live stock
Monthly eRaktKosh submissions are built from bags already in the system, validated, and submitted without re-keying into the national portal. Rejections surface for correction instead of arriving weeks later as a surprise.
Biometrics, camps, and cloud operations
Fingerprint-backed donor identity, tablet-ready camp registration with same-day stock reconciliation, named role-based accounts with audit history, and cloud deployment so multi-location centres share donor and inventory truth without per-site servers.
Leaving is not a hold
A complete export of registers and records in openable formats is available on request at no charge. Schedule F retention outlasts any contract — charging for access to compliance records is a hold no blood centre should accept.
Three questions to put to Sara Technologies, and to us
Ask both vendors the same three and compare the answers rather than the brochures.
- Is the blood bank system a product with a shared release cycle and other live centres on the same version, or is each deployment developed for that client?
- How many blood centres run it today, in which states, and can you speak to one of similar size?
- When a national eRaktKosh or ABDM schema change lands, is the update absorbed for all clients or quoted per client?
Review eBloodConnect features before the call, then book a demo on your own formats.
Questions about this comparison
More comparisons
See eBloodConnect on your own registers
Send your register formats, analyser models, and state. We will run ABDM M1–M3 and eRaktKosh flows on those rather than on sample data.
